Brief: Abion Presents New Efficacy Data For Abn401, A Novel Met Tki For Advanced Non-Small Cell Lung Cancer

ABion

13/10/2023 13:08

Oct 13 (Reuters) - Abion Inc  203400.KQ :
    * ABION PRESENTS NEW EFFICACY DATA FOR ABN401, A NOVEL MET
TKI FOR
ADVANCED NON-SMALL CELL LUNG CANCER
    * ABION INC - ABN401 DEMONSTRATES SUPERIOR SAFETY PROFILE TO
EXISTING TREATMENTS

Source text for Eikon:  ID:nBw175W2Xa 
Further company coverage:  203400.KQ 

 ((Reuters.Briefs@thomsonreuters.com))